Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.
Publication
, Journal Article
Gradishar, WJ; Anderson, BO; Balassanian, R; Blair, SL; Burstein, HJ; Cyr, A; Elias, AD; Farrar, WB; Forero, A; Giordano, SH; Goetz, MP ...
Published in: J Natl Compr Canc Netw
March 2018
Ductal carcinoma in situ (DCIS) of the breast represents a heterogeneous group of neoplastic lesions in the breast ducts. The goal for management of DCIS is to prevent the development of invasive breast cancer. This manuscript focuses on the NCCN Guidelines Panel recommendations for the workup, primary treatment, risk reduction strategies, and surveillance specific to DCIS.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
March 2018
Volume
16
Issue
3
Start / End Page
310 / 320
Location
United States
Related Subject Headings
- Watchful Waiting
- Treatment Outcome
- Retreatment
- Oncology & Carcinogenesis
- Humans
- Female
- Disease Management
- Combined Modality Therapy
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Ductal, Breast
Citation
APA
Chicago
ICMJE
MLA
NLM
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., … Shead, D. A. (2018). Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 16(3), 310–320. https://doi.org/10.6004/jnccn.2018.0012
Gradishar, William J., Benjamin O. Anderson, Ron Balassanian, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony D. Elias, et al. “Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 16, no. 3 (March 2018): 310–20. https://doi.org/10.6004/jnccn.2018.0012.
Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, et al. Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 Mar;16(3):310–20.
Gradishar, William J., et al. “Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw, vol. 16, no. 3, Mar. 2018, pp. 310–20. Pubmed, doi:10.6004/jnccn.2018.0012.
Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz MP, Goldstein LJ, Isakoff SJ, Lyons J, Marcom PK, Mayer IA, McCormick B, Moran MS, O’Regan RM, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Sitapati A, Smith KL, Smith ML, Soliman H, Somlo G, Telli ML, Ward JH, Kumar R, Shead DA. Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 Mar;16(3):310–320.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
March 2018
Volume
16
Issue
3
Start / End Page
310 / 320
Location
United States
Related Subject Headings
- Watchful Waiting
- Treatment Outcome
- Retreatment
- Oncology & Carcinogenesis
- Humans
- Female
- Disease Management
- Combined Modality Therapy
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Ductal, Breast